We are the point of contact for all legal matters that may arise in the everyday life of an enterprise. We assist companies in their formation, organization or liquidation, we provide support in the preparation and holding of shareholders' meetings and support board members and managing directors in the performance of their duties.
In addition, we advise our clients on acquisitions and sales of companies or businesses (M&A), private equity and venture capital transactions, restructurings, debt financing and related tax issues. We are also a recognised representative at the SIX Swiss Exchange AG pursuant to Art. 58a of the Listing Rules.
Contact Partner: Thomas Peter
Unterlässt es ein Verwaltungsratsmitglied, in einem gegen die AG gerichteten Prozess diese angemessen zu verteidigen, kann das Verwaltungsratsmitglied wegen aktienrechtlicher Sorgfaltspflichtverletzung i.S.v. Art. 754 OR für den dadurch entstandenen Schaden persönlich haften (BGer 4A_506/2024 vom 18. März 2025).
Bratschi AG advised Zürcher Kantonalbank, acting as mandated lead arranger and agent, on a CHF 220 million syndicated, mortgage-backed revolving credit facility granted to Urban Assets Zug AG. The facility supports the financing of real estate development projects on «Tech Cluster Zug», a former industrial site located in northern Zug.
Urban Assets Zug AG is held by Metall Zug AG, a Swiss holding company with a diversified portfolio comprising three directly controlled business units and strategic investments in Swiss small-cap industrial companies. Headquartered in Zug, Switzerland, Metall Zug employs around 1,000 people worldwide.
The Bratschi team was led by Barbara Jecklin (Finance) and further included Thomas Schönenberger (Real Estate).
The Viking Cruises Group has successfully placed an unsecured bond in the total amount of USD 1.7 billion. BofA Securities, Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, HSBC Securities (USA) Inc., Morgan Stanley & Co. LLC and UBS Securities LLC acted as Joint Book-Running Managers.
HAS Healthcare Advanced Synthesis SA has acquired Chemholding due SA and its subsidiaries. The main operating company is Cerbios-Pharma SA.